Friday, March 27, 2020

FDA opens up Bellerophon's gas therapy for COVID-19, stock rockets

FDA opens up Bellerophon's gas therapy for COVID-19, stock rockets

Friday, March 20, 2020
Using a regulatory pathway that allows patients with life-threatening conditions to use unapproved therapies, the FDA has granted “emergency expanded access” to Bellerophon Therapeutics’ inhaled nitric oxide delivery system for treating the novel coronavirus.

No comments: